查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954677

全球數位PCR市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察以及未來預測（2026-2034）

Digital PCR Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

數位PCR市場成長驅動因素

由於對高精度分子診斷的需求不斷成長、傳染病和遺傳疾病的蔓延以及技術的持續進步，全球數位PCR（dPCR）市場正經歷快速成長。2025年市場規模為8.572億美元，預計2026年將成長至10.432億美元。到2034年，市場規模預計將達到57.7673億美元，2026年至2034年的年複合成長率高達23.90%。

北美地區在2025年以43.70%的市場佔有率引領全球市場，這得益於其對先進分子診斷技術的早期應用以及強大的生物製藥研發基礎設施。

市場概覽

數位聚合酶鍊式反應（dPCR）是傳統PCR技術的升級版，能夠對核酸（DNA/RNA）進行絕對定量。與即時PCR相比，dPCR具有更高的靈敏度、準確性和可重複性。主要優點包括高通量能力、更高的偵測精度、成本效益和更快的處理速度。

傳染病、癌症和遺傳疾病病例的不斷增加是數位PCR市場的主要驅動力。收購增加、產品發布以及實驗室應用範圍的擴大進一步推動了行業成長。數位平台的技術進步也顯著促進了市場擴張。

新冠疫情的影響

新冠疫情對數位PCR市場產生了正面影響。2020年，在全球對精準新冠病毒診斷需求激增的背景下，該市場實現了38.6%的顯著成長，高於2019年的18.1%。

檢測量的激增促使臨床實驗室和研究機構更多地採用數位PCR設備。儘管疫情後 COVID-19 病例減少導致檢測量下降，但由於2021年常規診斷的恢復以及腫瘤學和基因檢測應用領域的擴展，需求仍然強勁。用於生物製藥應用的數位 PCR（dPCR）檢測和設備的持續創新，進一步增強了市場在2025年至2034年預測期內的成長動力。

數位 PCR 市場趨勢

從液滴式數位 PCR 過渡到晶片式數位 PCR 的

市場的一個顯著趨勢是從基於液滴的數位 PCR（ddPCR）逐步過渡到基於晶片的系統。雖然液滴系統目前仍佔據主導地位，但基於晶片的技術可以降低交叉污染的風險並提高工作流程效率。基於晶片的檢測具有處理速度更快、更便捷、更經濟高效等優勢。

不斷上升的感染率和日益嚴重的癌症負擔加速先進的基於晶片的數位 PCR 技術的應用。預計這一轉變將在預測期內進一步推動數位PCR市場的成長。

市場成長驅動因素

技術進步

數位PCR系統（液滴、晶片、光束、晶體反應技術等）的持續創新顯著提升了其性能和應用範圍。市場參與者推出全自動整合系統，以支援檢測和體外診斷應用。

公營機構不斷增加的研發投入加速下一代dPCR平台的開發，並拓展其在腫瘤學、傳染病檢測和基因突變分析中的應用。

相對於即時PCR的優勢

數位PCR可實現無需標準曲線的絕對定量，並提供更高的靈敏度和準確性。它在檢測低病毒量和微小基因突變方面特別有效。這些優勢使其極為適用於癌症突變檢測和傳染病診斷等應用。

人們越來越傾向於選擇數位PCR而非傳統即時PCR，預計這將進一步加速其在全球的普及應用。

限制因子

儘管成長前景廣闊，但以下挑戰可能會限制其擴張：

  • 數位PCR設備成本高
  • 需要熟練的專業人員
  • 與次世代定序（NGS）等替代技術的競爭
  • 低收入地區難以取得微流控耗材

這些因素可能會減緩發展中國家的採用速度。

市場區隔分析

依類型

市場依類型細分為以下幾類：

  • 液滴式數位PCR
  • 晶片式數位PCR
  • 其他

到2026年，由於產品數量的增加，液滴式數位PCR細分市場將佔據主導地位，市場佔有率達到82.04%。傳染病診斷領域已推出多種新型診斷方法並廣泛應用。然而，由於晶片式系統在工作流程效率和污染控制方面具有優勢，因此預計將保持穩定成長。

依產品類別

  • 設備
  • 試劑和耗材

預計到2026年，設備細分市場將佔據 59.01%的市場佔有率，這主要得益於產品發布量的增加和系統整合技術的進步。

預計試劑和耗材細分市場將以最高的年複合成長率成長，這主要得益於診斷試劑盒商業化的擴展和檢測應用的增加。

依適應症類別

  • 傳染病
  • 腫瘤
  • 遺傳性疾病
  • 其他

預計遺傳性疾病細分市場將推動市場成長，到2026年將佔據 51.56%的市場佔有率，這主要得益於其在檢測基因突變方面的高靈敏度。

由於癌症發生率不斷上升，腫瘤學領域預計將以顯著的年複合成長率成長。由於數位 PCR 在病毒和細菌檢測方面經臨床驗證的有效性，預計傳染病領域將紀錄最高的年複合成長率。

依最終使用者劃分

  • 學術和研究機構
  • 臨床實驗室
  • 醫院和診所
  • 製藥和生技公司

學術和研究機構細分市場在2026年將以 67.90%的市場佔有率領先，反映出該技術在研究活動中的廣泛應用。

隨著傳染病檢測量的成長，臨床實驗室領域預計將以最高的年複合成長率擴張。

區域洞察

北美

北美地區在2025年創造 3.7468億美元的收入，繼續保持其在全球市場的主導地位。預計到2026年，美國市場規模將達到 4.2629億美元。強勁的研發投入和高技術普及率推動該地區的成長。

歐洲

在研發投入增加和政府主導措施的支持下，預計歐洲市場將以適度的年複合成長率成長。預計到2026年，德國市場規模將達到 8,264萬美元，英國市場規模將達到 3,309萬美元。

亞太地區

預計亞太地區在預測期內將以最高的年複合成長率成長。

  • 預計到2026年，日本市場規模將達到 5,098萬美元。
  • 預計到2026年，中國市場規模將達到 8,381萬美元。
  • 預計到2026年，印度市場規模將達到 3,093萬美元。

成長的驅動因素是醫療基礎設施的改善和較高的疾病負擔。

拉丁美洲、中東和非洲地區

由於醫療基礎設施的發展和臨床研究活動的增加，預計這些地區將經歷顯著成長。

該化合物預計2026年至2034年的年複合成長率（CAGR）為23.90%。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家和地區慢性病（癌症和傳染病）盛行率（2025年）
  • 主要產業趨勢：併購、業務合作等
  • 監理主要國家和地區概況
  • 數位PCR技術進展
  • 新冠疫情對市場的影響

第5章 全球數位PCR市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型
    • 液滴式數位PCR
    • 晶片式數位PCR
    • 其他
  • 市場分析、洞察與預測：依產品
    • 設備
    • 試劑和耗材
  • 市場分析、洞察與預測：依適應症
    • 傳染病
    • 腫瘤
    • 遺傳性疾病
    • 其他
  • 市場分析、洞察與預測：依最終用戶
    • 醫院和診所
    • 製藥和生物技術產業
    • 臨床實驗室
    • 學術和研究機構
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美數位PCR市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲數位PCR市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲地區

第8章 亞太數字PCR市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家/地區

第9章 拉丁美洲數位PCR市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家/地區國家/地區

第10章 中東與非洲數位 PCR 市場分析：洞察與預測（2021-2034）

  • 各國/地區概覽
    • GCC
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • JN Medsys
    • Stilla
    • Sysmex Corporation
    • Standard BioTools Inc.
    • Precigenome LLC.
Product Code: FBI102014

Growth Factors of digital PCR Market

The global digital PCR market is experiencing rapid expansion due to rising demand for high-precision molecular diagnostics, increasing prevalence of infectious and genetic diseases, and continuous technological advancements. The market was valued at USD 857.2 million in 2025 and is projected to grow to USD 1,043.20 million in 2026. It is expected to reach USD 5,776.73 million by 2034, registering a strong CAGR of 23.90% during 2026-2034.

North America dominated the global market with a 43.70% market share in 2025, supported by early adoption of advanced molecular diagnostic technologies and strong biopharmaceutical research infrastructure.

Market Overview

Digital Polymerase Chain Reaction (dPCR) is an advanced form of conventional PCR technology that enables absolute quantification of nucleic acids (DNA/RNA). It offers enhanced sensitivity, precision, and reproducibility compared to real-time PCR. Key advantages include high throughput capability, improved detection accuracy, cost-effectiveness, and faster processing.

Rising cases of infectious diseases, cancer, and genetic disorders are major drivers of the digital PCR market. Increased acquisitions, product launches, and expansion of laboratory adoption further support industry growth. Technological advancements in digital platforms are also contributing significantly to market expansion.

COVID-19 Impact

The COVID-19 pandemic positively impacted the digital PCR market. In 2020, the market recorded a substantial growth rate of 38.6%, compared to 18.1% in 2019, driven by massive global demand for accurate COVID-19 diagnostics.

The surge in testing volumes led to increased adoption of digital PCR devices in clinical laboratories and research institutes. Although post-pandemic decline in COVID-19 cases reduced testing volumes, the resumption of routine diagnostics in 2021 and growing applications in oncology and genetic testing sustained strong demand. Continuous innovation in dPCR assays and equipment for biopharmaceutical applications further strengthened market momentum heading into the 2025-2034 forecast period.

Digital PCR Market Trends

Shift from Droplet to Chip-Based Digital PCR

A notable trend in the market is the gradual shift from droplet-based digital PCR (ddPCR) to chip-based systems. While droplet systems dominate currently, chip-based technologies reduce risks of cross-contamination and improve workflow efficiency. Chip-based tests offer advantages such as faster processing, simplicity, and cost-effectiveness.

Increasing incidence of infectious diseases and growing cancer burden are accelerating adoption of advanced chip-based digital PCR technologies. This shift is expected to further drive the digital PCR market growth during the forecast period.

Market Growth Drivers

Technological Advancements

Continuous innovation in digital PCR systems-including droplet, chip-based, beam, and crystal reaction techniques-has significantly enhanced performance and application scope. Market players are launching fully automated integrated systems to support both research and in vitro diagnostic applications.

Increased R&D investments by public and private organizations are accelerating development of next-generation dPCR platforms, expanding their use in oncology, infectious disease testing, and genetic mutation analysis.

Advantages Over Real-Time PCR

Digital PCR offers absolute quantification without reliance on standard curves, delivering higher sensitivity and precision. It is particularly effective in detecting low viral loads and minor genetic variations. These advantages make it highly suitable for applications such as cancer mutation detection and infectious disease diagnosis.

Growing preference for digital PCR over traditional real-time PCR is expected to drive strong adoption globally.

Restraining Factors

Despite strong growth prospects, certain challenges may limit expansion:

  • High cost of digital PCR instruments
  • Requirement for skilled professionals
  • Competition from alternative technologies such as Next-Generation Sequencing (NGS)
  • Limited availability of microfluidic consumables in low-income regions

These factors may slow adoption in developing economies.

Market Segmentation Analysis

By Type

The market is segmented into:

  • Droplet Digital PCR
  • Chip-Based Digital PCR
  • Others

The droplet dPCR segment dominated with a 82.04% market share in 2026, driven by increasing product launches and widespread use in infectious disease diagnostics. However, chip-based systems are projected to grow steadily due to workflow efficiency and contamination control advantages.

By Product

  • Instruments
  • Reagents & Consumables

The instruments segment accounted for 59.01% market share in 2026, supported by rising product launches and advanced system integration.

The reagents & consumables segment is expected to grow at the highest CAGR, fueled by increasing commercialization of diagnostic kits and expanding research applications.

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

The genetic disorders segment dominated with 51.56% share in 2026, driven by high sensitivity in detecting gene mutations.

The oncology segment is projected to grow at a substantial CAGR due to increasing cancer prevalence. The infectious diseases segment is expected to register the highest CAGR owing to the clinically proven effectiveness of digital PCR in viral and bacterial detection.

By End User

  • Academic & Research Organizations
  • Clinical Laboratories
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies

The academic & research organizations segment led the market with 67.90% share in 2026, reflecting extensive use in research studies.

The clinical laboratories segment is expected to expand at the highest CAGR due to growing infectious disease testing volumes.

Regional Insights

North America

North America generated USD 374.68 million in 2025, maintaining dominance in the global market. The U.S. market is projected to reach USD 426.29 million in 2026. Strong research funding and high technology adoption drive regional growth.

Europe

Europe is projected to grow at a moderate CAGR, supported by increasing R&D investments and government initiatives. Germany is expected to reach USD 82.64 million in 2026, while the UK is projected at USD 33.09 million in 2026.

Asia Pacific

Asia Pacific is expected to grow at the highest CAGR during the forecast period.

  • Japan market projected at USD 50.98 million in 2026
  • China market projected at USD 83.81 million in 2026
  • India market projected at USD 30.93 million in 2026

Growth is driven by improving healthcare infrastructure and high disease burden.

Latin America & Middle East & Africa

These regions are projected to witness significant growth due to improving healthcare infrastructure and increasing clinical research activities.

Competitive Landscape

The digital PCR market is consolidated, with leading players including:

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Stilla
  • Sysmex Corporation
  • Standard BioTools Inc.
  • JN Medsys

Bio-Rad Laboratories holds a dominant position due to its strong droplet digital PCR portfolio and strategic acquisitions. Partnerships, product launches, and geographic expansion strategies are strengthening the competitive landscape.

Conclusion

The global digital PCR market is poised for remarkable growth from USD 857.2 million in 2025 to USD 5,776.73 million by 2034, driven by rising infectious and genetic disease prevalence, technological advancements, and expanding research applications. With a projected CAGR of 23.90% from 2026-2034, the market is expected to witness substantial expansion, particularly across North America and Asia Pacific, positioning digital PCR as a critical technology in the future of molecular diagnostics.

Growth Rate CAGR of 23.90% from 2026-2034

Segmentation

By Type

  • Droplet Digital PCR
  • Chip-based Digital PCR
  • Others

By Product

  • Instruments
  • Reagents & Consumables

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

By End-user

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Industries
  • Clinical Laboratories
  • Academic & Research Organizations

By Geography

  • North America (By Type, Product, By Indication, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Product, By Indication, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Chronic Diseases (Cancer and Infectious Disease), By Key Countries/Regions, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Regulatory Scenario, By Key Countries/Region
  • 4.4. Technological Advancements in Digital PCR
  • 4.5. Impact of Covid-19 on the Market

5. Global Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Droplet Digital PCR
    • 5.1.2. Chip-based Digital PCR
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Instruments
    • 5.2.2. Reagents & Consumables
  • 5.3. Market Analysis, Insights and Forecast - By Indication
    • 5.3.1. Infectious Diseases
    • 5.3.2. Oncology
    • 5.3.3. Genetic Disorders
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & Clinics
    • 5.4.2. Pharmaceutical & Biotechnology Industries
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Academic & Research Organisations
  • 5.5. Market Analysis, Insights and Forecast - By Geography
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Droplet Digital PCR
    • 6.1.2. Chip-based Digital PCR
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Instruments
    • 6.2.2. Reagents & Consumables
  • 6.3. Market Analysis, Insights and Forecast - By Indication
    • 6.3.1. Infectious Diseases
    • 6.3.2. Oncology
    • 6.3.3. Genetic Disorders
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Pharmaceutical & Biotechnology Industries
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Academic & Research Organisations
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Droplet Digital PCR
    • 7.1.2. Chip-based Digital PCR
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Instruments
    • 7.2.2. Reagents & Consumables
  • 7.3. Market Analysis, Insights and Forecast - By Indication
    • 7.3.1. Infectious Diseases
    • 7.3.2. Oncology
    • 7.3.3. Genetic Disorders
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Pharmaceutical & Biotechnology Industries
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Academic & Research Organisations
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Droplet Digital PCR
    • 8.1.2. Chip-based Digital PCR
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Instruments
    • 8.2.2. Reagents & Consumables
  • 8.3. Market Analysis, Insights and Forecast - By Indication
    • 8.3.1. Infectious Diseases
    • 8.3.2. Oncology
    • 8.3.3. Genetic Disorders
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Pharmaceutical & Biotechnology Industries
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Academic & Research Organisations
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of APAC

9. Latin America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Droplet Digital PCR
    • 9.1.2. Chip-based Digital PCR
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Instruments
    • 9.2.2. Reagents & Consumables
  • 9.3. Market Analysis, Insights and Forecast - By Indication
    • 9.3.1. Infectious Diseases
    • 9.3.2. Oncology
    • 9.3.3. Genetic Disorders
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & Clinics
    • 9.4.2. Pharmaceutical & Biotechnology Industries
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Academic & Research Organisations
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Droplet Digital PCR
    • 10.1.2. Chip-based Digital PCR
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Product
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Consumables
  • 10.3. Market Analysis, Insights and Forecast - By Indication
    • 10.3.1. Infectious Diseases
    • 10.3.2. Oncology
    • 10.3.3. Genetic Disorders
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Pharmaceutical & Biotechnology Industries
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Academic & Research Organisations
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Bio-Rad Laboratories, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. JN Medsys
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. Stilla
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. Sysmex Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. Standard BioTools Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. Precigenome LLC.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (based on availability)

List of Tables

  • Table 1: Global Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 3: Global Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 4: Global Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 5: Global Digital PCR Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 7: North America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 8: North America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 9: North America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 10: North America Digital PCR Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: Europe Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Europe Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 13: Europe Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 14: Europe Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 15: Europe Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 18: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 19: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Latin America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 23: Latin America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 24: Latin America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 28: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 29: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital PCR Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Digital PCR Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Digital PCR Market Value Share (%), by Product, 2025 & 2034
  • Figure 4: Global Digital PCR Market Value Share (%), by Indication, 2025 & 2034
  • Figure 5: Global Digital PCR Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Figure 7: North America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 8: North America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 9: North America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 10: North America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 11: North America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 12: North America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 13: North America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: North America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 15: North America Digital PCR Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Digital PCR Market Value Share (%), By Country, 2025
  • Figure 17: Europe Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Europe Digital PCR Market Value Share (%), by Type, 2025
  • Figure 19: Europe Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 20: Europe Digital PCR Market Value Share (%), by Product, 2025
  • Figure 21: Europe Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 22: Europe Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 23: Europe Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 24: Europe Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Digital PCR Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 30: Asia Pacific Digital PCR Market Value Share (%), by Product, 2025
  • Figure 31: Asia Pacific Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 32: Asia Pacific Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 33: Asia Pacific Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 38: Latin America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 40: Latin America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 41: Latin America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 42: Latin America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 43: Latin America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 44: Latin America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Digital PCR Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 50: Middle East & Africa Digital PCR Market Value Share (%), by Product, 2025
  • Figure 51: Middle East & Africa Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 52: Middle East & Africa Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 53: Middle East & Africa Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Digital PCR Market Share (%), By Company, 2025